Literature DB >> 19204097

Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae.

S Dégrange1, C Cazanave, A Charron, H Renaudin, C Bébéar, C M Bébéar.   

Abstract

In this study we report on the development of a multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) method for the molecular typing of Mycoplasma pneumoniae. The genomic content of M. pneumoniae M129 was analyzed for VNTRs, and 5 of the 17 VNTRs identified were selected for use in an MLVA assay. The method was based on a GeneScan analysis of VNTR loci labeled with fluorescent dyes by multiplex PCR and capillary electrophoresis. This approach was applied to a collection of 265 isolates from various European countries, Japan, and Tunisia; and 26 distinct VNTR types were found. The VNTR assay was compared to the P1 adhesin PCR-restriction fragment length polymorphism (RFLP) typing method and showed a far better resolution than the P1 PCR-RFLP method. The discriminatory power of MLVA (Hunter-Gaston diversity index [HGDI], 0.915) for the 265 isolates was significantly higher than that of the P1 PCR-RFLP method (HGDI, 0.511). However, there was a correlation between the typing results obtained by MLVA and the P1 gene PCR-RFLP method. The potential value of MLVA of M. pneumoniae as an epidemiological tool is discussed, and the use of the VNTR markers in further investigations of the potential use of MLVA in outbreaks of M. pneumoniae infections is proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204097      PMCID: PMC2668363          DOI: 10.1128/JCM.01935-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Identification of a new variable sequence in the P1 cytadhesin gene of Mycoplasma pneumoniae: evidence for the generation of antigenic variation by DNA recombination between repetitive sequences.

Authors:  T Kenri; R Taniguchi; Y Sasaki; N Okazaki; M Narita; K Izumikawa; M Umetsu; T Sasaki
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples.

Authors:  Roger Dumke; Paul Christian Lück; Christoph Noppen; Christoph Schaefer; Heike von Baum; Reinhard Marre; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

3.  Identification and characterization of variable-number tandem-repeat markers for the molecular epidemiological analysis of Mycoplasma mycoides subspecies mycoides SC.

Authors:  Laura McAuliffe; Roger D Ayling; Robin A J Nicholas
Journal:  FEMS Microbiol Lett       Date:  2007-11       Impact factor: 2.742

4.  Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease.

Authors:  Eyal Klement; Deborah F Talkington; Oshri Wasserzug; Raid Kayouf; Nadav Davidovitch; Roger Dumke; Yael Bar-Zeev; Merav Ron; Jonathan Boxman; W Lanier Thacker; Dana Wolf; Tsilia Lazarovich; Yonat Shemer-Avni; Daniel Glikman; Enno Jacobs; Itamar Grotto; Colin Block; Ran Nir-Paz
Journal:  Clin Infect Dis       Date:  2006-10-05       Impact factor: 9.079

5.  Isolation of Mycoplasma pneumoniae from pericardial tissue.

Authors:  M A Meseguer; S García-Rull; J Picher; J Ortiz-Saracho; L Maíz; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

6.  Epidemiological study of Mycoplasma pneumoniae infections in japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene.

Authors:  T Sasaki; T Kenri; N Okazaki; M Iseki; R Yamashita; M Shintani; Y Sasaki; M Yayoshi
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Authors:  Mayumi Matsuoka; Mitsuo Narita; Norio Okazaki; Hitomi Ohya; Tsutomu Yamazaki; Kazunobu Ouchi; Isao Suzuki; Tomoaki Andoh; Tsuyoshi Kenri; Yuko Sasaki; Atsuko Horino; Miharu Shintani; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Guidelines for the validation and application of typing methods for use in bacterial epidemiology.

Authors:  A van Belkum; P T Tassios; L Dijkshoorn; S Haeggman; B Cookson; N K Fry; V Fussing; J Green; E Feil; P Gerner-Smidt; S Brisse; M Struelens
Journal:  Clin Microbiol Infect       Date:  2007-10       Impact factor: 8.067

Review 9.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

10.  First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.

Authors:  S Pereyre; A Charron; H Renaudin; C Bébéar; C M Bébéar
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

View more
  68 in total

1.  Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Authors:  T R Kannan; R D Hardy; J J Coalson; D C Cavuoti; J D Siegel; M Cagle; O Musatovova; C Herrera; J B Baseman
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

2.  Sequence variation within the P1 gene of Mycoplasma pneumoniae.

Authors:  Emiel B M Spuesens; Nico G Hartwig; Annemarie M C van Rossum; Cornelis Vink
Journal:  J Clin Microbiol       Date:  2011-10       Impact factor: 5.948

3.  Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis.

Authors:  Yang Liu; Xinye Ye; Hong Zhang; Xiaogang Xu; Minggui Wang
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

4.  Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China.

Authors:  Chao Yan; Hongmei Sun; Stella Lee; Rangaraj Selvarangan; Xuan Qin; Yi-Wei Tang; Ken B Waites; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

5.  Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.

Authors:  Yang Liu; Xinyu Ye; Hong Zhang; Xiaogang Xu; Wanhua Li; Demei Zhu; Minggui Wang
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

6.  Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university.

Authors:  Jessica L Waller; Maureen H Diaz; Brianna L Petrone; Alvaro J Benitez; Bernard J Wolff; Laura Edison; Melissa Tobin-D'Angelo; Ashley Moore; Audrey Martyn; Hope Dishman; Cherie L Drenzek; Kim Turner; Lauri A Hicks; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

7.  Identification of P1 variants of Mycoplasma pneumoniae by use of high-resolution melt analysis.

Authors:  Stephanie B Schwartz; Stephanie L Mitchell; Kathleen A Thurman; Bernard J Wolff; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

8.  Study of Two Separate Types of Macrolide-Resistant Mycoplasma pneumoniae Outbreaks.

Authors:  Yingshuo Wang; Qian Ye; Dehua Yang; Zhimin Ni; Zhimin Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  Sequence analysis of the p1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009.

Authors:  Fei Zhao; Bin Cao; Jing Li; Sufan Song; Xiaoxia Tao; Yudong Yin; Lihua He; Jianzhong Zhang
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

10.  Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.

Authors:  Toni Whistler; Pongpun Sawatwong; Maureen H Diaz; Alvaro J Benitez; Bernard J Wolff; Patranuch Sapchookul; Somsak Thamthitiwat; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.